Join to View Full Profile
1600 S Brentwood Blvd Ste 700Brentwood, MO 63144
Phone+1 314-367-1181
Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- William Anderson, MD, is an ophthalmologist located in Brentwood, MO, specializing in retinal disease. He completed his medical education in 2019 at Saint Louis University School of Medicine. Dr. Anderson has contributed to various publications, including a notable article on the mechanisms of sterile inflammation following intravitreal injections, significantly cited by other works. He has also published articles on a range of topics such as myopic maculopathy, crystalline precipitates from intravitreal methotrexate, and case reports on central serous chorioretinopathy and neuro-ophthalmological issues like diplopia and nystagmus.
Education & Training
Saint Louis University School of MedicineClass of 2019
Certifications & Licensure
IL State Medical License 2023 - 2026
MO State Medical License 2019 - 2026
American Board of Anesthesiology Anesthesiology
American Board of Ophthalmology Ophthalmology
Clinical Trials
- Pivotal Study of OCS-01 Eye Drops in Subjects with Diabetic Macular Edema (DIAMOND-2) Start of enrollment: 2024 Mar 15
- Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (axitinib Implant) in Subjects with Neovascular Age-Related Macular Degeneration Start of enrollment: 2024 Jan 29
Publications & Presentations
PubMed
- Crystalline Precipitates Secondary to Intravitreal Methotrexate.William J Anderson, Athanasios Papakostas, Kevin J Blinder
Retina. 2025-04-01 - 4 citationsManagement of Myopic Maculopathy: A Review.William J Anderson, Levent Akduman
Turkish Journal of Ophthalmology. 2023-10-19 - Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone.William J Anderson, Bradley T Smith
American Journal of Ophthalmology Case Reports. 2022-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
